{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:12:22Z","timestamp":1777615942419,"version":"3.51.4"},"reference-count":69,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2014,7,21]],"date-time":"2014-07-21T00:00:00Z","timestamp":1405900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Foot &amp; Ankle Specialist"],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:p>This review intends to provide guidance regarding perioperative management of anticoagulation and antiplatelet drug therapy as they relate to foot and ankle surgery. Venous and arterial thromboembolism are conditions in which the blood clots inappropriately, causing considerable morbidity and mortality. With an increase in awareness of thromboembolic risk factors and expansion of therapeutic options, more patients are routinely taking antithrombotic medication. When these patients require invasive procedures, a decision needs to be made if antithrombotic medication should be held perioperatively and if additional precautions are needed in the interim. Understanding the factors affecting the management of thromboembolism during the perioperative period can reduce the potential for complications.<\/jats:p>\n                  <jats:p>Levels of Evidence: Therapeutic, Level V: Expert opinion<\/jats:p>","DOI":"10.1177\/1938640014543356","type":"journal-article","created":{"date-parts":[[2014,7,22]],"date-time":"2014-07-22T23:11:34Z","timestamp":1406070694000},"page":"507-514","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Balancing the Risk of Complications in Foot and Ankle Surgical Patients Taking Antithrombotic Medication"],"prefix":"10.1177","volume":"7","author":[{"given":"Steven","family":"Miller","sequence":"first","affiliation":[{"name":"Skokie Foot & Ankle Specialists, Skokie, Illinois (SM)"},{"name":"Thrombosis and Anticoagulation Unit of Glenbrook Hospital, NorthShore University HealthSystem, Glenview, Illinois (DNG)"},{"name":"Division of Vascular Surgery, NorthShore University HealthSystem, Evanston, Illinois (JAC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane","family":"Nitzki-George","sequence":"additional","affiliation":[{"name":"Skokie Foot & Ankle Specialists, Skokie, Illinois (SM)"},{"name":"Thrombosis and Anticoagulation Unit of Glenbrook Hospital, NorthShore University HealthSystem, Glenview, Illinois (DNG)"},{"name":"Division of Vascular Surgery, NorthShore University HealthSystem, Evanston, Illinois (JAC)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph A.","family":"Caprini","sequence":"additional","affiliation":[{"name":"Skokie Foot & Ankle Specialists, Skokie, Illinois (SM)"},{"name":"Thrombosis and Anticoagulation Unit of Glenbrook Hospital, NorthShore University HealthSystem, Glenview, Illinois (DNG)"},{"name":"Division of Vascular Surgery, NorthShore University HealthSystem, Evanston, Illinois (JAC)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2014,7,21]]},"reference":[{"key":"bibr1-1938640014543356","first-page":"983","volume-title":"Harrison\u2019s Principles of Internal Medicine","volume":"2012","author":"Freedman JE","edition":"18"},{"key":"bibr2-1938640014543356","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-12-200706190-00007"},{"key":"bibr3-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e3181f7d043"},{"key":"bibr4-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e318266722a"},{"key":"bibr5-1938640014543356","first-page":"187","volume":"78","author":"Radovanovic I","year":"2012","journal-title":"Acta Orthop Belg"},{"key":"bibr6-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1021\/bi00107a001"},{"key":"bibr7-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.017"},{"key":"bibr8-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)86176-8"},{"key":"bibr9-1938640014543356","unstructured":"Xarelto [package insert]. Titusville, NJ: Janssen Pharamceuticals; 2011."},{"key":"bibr10-1938640014543356","unstructured":"Eliquis [package insert]. Princeton, NJ: Bristol-Myers Squibb; 2012."},{"key":"bibr11-1938640014543356","unstructured":"Pradaxa [package insert]. Ridgefield, CT: Boehringer Ingelheim Pharamceutical; 2013."},{"key":"bibr12-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1097\/NOR.0b013e31826649a0"},{"key":"bibr13-1938640014543356","first-page":"52","volume":"52","author":"Tsiara S","year":"2011","journal-title":"Hellenic J Cardiol"},{"key":"bibr14-1938640014543356","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: update on the risk for serious bleeding events with the anticoagulant Pradaxa (dabigatran). http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm326580.htm. Accessed June 26, 2013."},{"key":"bibr15-1938640014543356","unstructured":"US Food and Drug Administration. Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication: safety review of post-market reports of serious bleeding events. http:\/\/www.fda.gov\/safety\/medwatch\/safetyinformation\/safetyalertsforhumanmedicalproducts\/ucm282820.htm. Accessed June 26, 2013."},{"key":"bibr16-1938640014543356","unstructured":"ISMP Quarterly Report: Monitoring FDA medwatch reports. http:\/\/www.ismp.org\/QuarterWatch\/pdfs\/2012Q2.pdf. Accessed June 26, 2013."},{"key":"bibr17-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1103053"},{"key":"bibr18-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.12.1319"},{"key":"bibr19-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6313.375"},{"key":"bibr20-1938640014543356","first-page":"2153","volume":"70","author":"Rupprecht HJ","year":"2010","journal-title":"Drugs"},{"key":"bibr21-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.16.1610"},{"key":"bibr22-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108941"},{"key":"bibr23-1938640014543356","unstructured":"Plavix [package insert]. Bridgewater, NJ: Bristol-Myers Squibb\/Sanofi Pharmaceuticals; 2011."},{"key":"bibr24-1938640014543356","unstructured":"Effient [package insert]. Indianapolis, IN: Daiichi Sankyo and Eli Lilly; 2012."},{"key":"bibr25-1938640014543356","unstructured":"Brilinta [package insert]. Wilmington, DE: AstraZeneca LP; 2013."},{"key":"bibr26-1938640014543356","unstructured":"Pletal [package insert]. Rockville, MD: Otsuka American Pharmaceuticals; 2007."},{"key":"bibr27-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2294"},{"key":"bibr28-1938640014543356","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.G.01370"},{"key":"bibr29-1938640014543356","volume-title":"Consultative Hemostasis and Thrombosis","author":"Kitchens CS","year":"2013","edition":"3"},{"key":"bibr30-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.135681"},{"key":"bibr31-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.06.019"},{"key":"bibr32-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1177\/1938640012463057"},{"key":"bibr33-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-8422(03)00007-7"},{"key":"bibr34-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2298"},{"key":"bibr35-1938640014543356","unstructured":"National Institutes of Health Clinical Center. A safety and effectiveness study of LMWH bridging therapy versus placebo bridging therapy for patients on long term warfarin and require temporary interruption of their warfarin (PERIOP2). ClinicalTrials.gov Web site NCT00432796."},{"key":"bibr36-1938640014543356","unstructured":"National Institutes of Health Clinical Center. Effectiveness of Bridging Anticoagulation for Surgery (the BRIDGE Study). ClinicalTrials.gov Web site NCT00786474."},{"key":"bibr37-1938640014543356","unstructured":"Canadian Institutes of Health Research. Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial (BRUISECONTROL). ClinicalTrials.gov Web site NCT00800137."},{"key":"bibr38-1938640014543356","doi-asserted-by":"publisher","DOI":"10.5435\/00124635-201012000-00003"},{"key":"bibr39-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3669.012k49_3669_3677"},{"key":"bibr40-1938640014543356","unstructured":"Kinney TB, Panko JE, Funaki BS, et al; Expert Panel on Interventional Radiology. ACR Appropriateness Criteria\u00ae radiologic management of inferior vena cava filters [online publication]. Reston, VA: American College of Radiology; 2009. http:\/\/www.guideline.gov\/content.aspx?id=15730. Accessed June 26, 2013."},{"key":"bibr41-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2297"},{"key":"bibr42-1938640014543356","unstructured":"Kcentra [package insert]. Kankakee, IL: CSL Behring; 2013."},{"key":"bibr43-1938640014543356","unstructured":"US Food and Drug Administration. FDA approves Kcentra for the urgent reversal of anticoagulation in adults with major bleeding. April 29, 2013. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm350026.htm. Accessed June 26, 2013."},{"key":"bibr44-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2292"},{"key":"bibr45-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2291"},{"key":"bibr46-1938640014543356","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130040"},{"key":"bibr47-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0b013e3182459a79"},{"key":"bibr48-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2013.04.009"},{"key":"bibr49-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12149"},{"key":"bibr50-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2009.03429.x"},{"key":"bibr51-1938640014543356","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.80a.13025"},{"key":"bibr52-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2013.07.011"},{"key":"bibr53-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.01.010"},{"key":"bibr54-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1R724"},{"key":"bibr55-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aet160"},{"key":"bibr56-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-2197.2010.05631.x"},{"key":"bibr57-1938640014543356","doi-asserted-by":"publisher","DOI":"10.3810\/hp.2013.02.1013"},{"key":"bibr58-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-009-0265-0"},{"key":"bibr59-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e318228c690"},{"key":"bibr60-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e31825aff10"},{"key":"bibr61-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1097\/ACO.0b013e32832eb8ab"},{"key":"bibr62-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eut083"},{"key":"bibr63-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.3.922"},{"key":"bibr64-1938640014543356","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20100104-08"},{"key":"bibr65-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61751-7"},{"key":"bibr66-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.03.044"},{"key":"bibr67-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2011.00444.x"},{"key":"bibr68-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1310399"},{"key":"bibr69-1938640014543356","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-11-0868"}],"container-title":["Foot &amp; Ankle Specialist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1938640014543356","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1938640014543356","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1938640014543356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:32:45Z","timestamp":1777411965000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1938640014543356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,21]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["10.1177\/1938640014543356"],"URL":"https:\/\/doi.org\/10.1177\/1938640014543356","relation":{},"ISSN":["1938-6400","1938-7636"],"issn-type":[{"value":"1938-6400","type":"print"},{"value":"1938-7636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,21]]}}}